These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 35348415)

  • 1. The Dual Nature of Microglia in Alzheimer's Disease: A Microglia-Neuron Crosstalk Perspective.
    Xie Z; Meng J; Wu Z; Nakanishi H; Hayashi Y; Kong W; Lan F; Narengaowa ; Yang Q; Qing H; Ni J
    Neuroscientist; 2023 Oct; 29(5):616-638. PubMed ID: 35348415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
    Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
    Elife; 2020 Jun; 9():. PubMed ID: 32510331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microglia-Mediated Synapse Loss in Alzheimer's Disease.
    Rajendran L; Paolicelli RC
    J Neurosci; 2018 Mar; 38(12):2911-2919. PubMed ID: 29563239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential Alzheimer's disease drug targets identified through microglial biology research.
    Lepiarz-Raba I; Hidayat T; Hannan AJ; Jawaid A
    Expert Opin Drug Discov; 2024 May; 19(5):587-602. PubMed ID: 38590098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microglia in Alzheimer's Disease: A Favorable Cellular Target to Ameliorate Alzheimer's Pathogenesis.
    Sumsuzzman DM; Uddin MS; Kabir MT; Hasana S; Perveen A; Alanazi IS; Albadrani GM; Abdel-Daim MM; Ashraf GM
    Mediators Inflamm; 2022; 2022():6052932. PubMed ID: 35693110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TLR4 Cross-Talk With NLRP3 Inflammasome and Complement Signaling Pathways in Alzheimer's Disease.
    Yang J; Wise L; Fukuchi KI
    Front Immunol; 2020; 11():724. PubMed ID: 32391019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aβ oligomers trigger necroptosis-mediated neurodegeneration via microglia activation in Alzheimer's disease.
    Salvadores N; Moreno-Gonzalez I; Gamez N; Quiroz G; Vegas-Gomez L; Escandón M; Jimenez S; Vitorica J; Gutierrez A; Soto C; Court FA
    Acta Neuropathol Commun; 2022 Mar; 10(1):31. PubMed ID: 35264247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of amyloid on microglia-neuron interactions before plaque onset occurs independently of TREM2 in a mouse model of Alzheimer's disease.
    von Saucken VE; Jay TR; Landreth GE
    Neurobiol Dis; 2020 Nov; 145():105072. PubMed ID: 32890775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CX3CL1 Pathway as a Molecular Target for Treatment Strategies in Alzheimer's Disease.
    Bivona G; Iemmolo M; Ghersi G
    Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37175935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological targeting of microglia dynamics in Alzheimer's disease: Preclinical and clinical evidence.
    Yousefizadeh A; Piccioni G; Saidi A; Triaca V; Mango D; Nisticò R
    Pharmacol Res; 2022 Oct; 184():106404. PubMed ID: 35988869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-146a switches microglial phenotypes to resist the pathological processes and cognitive degradation of Alzheimer's disease.
    Liang C; Zou T; Zhang M; Fan W; Zhang T; Jiang Y; Cai Y; Chen F; Chen X; Sun Y; Zhao B; Wang Y; Cui L
    Theranostics; 2021; 11(9):4103-4121. PubMed ID: 33754051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microglial Trem2 induces synaptic impairment at early stage and prevents amyloidosis at late stage in APP/PS1 mice.
    Sheng L; Chen M; Cai K; Song Y; Yu D; Zhang H; Xu G
    FASEB J; 2019 Sep; 33(9):10425-10442. PubMed ID: 31219699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glial cells in Alzheimer's disease: From neuropathological changes to therapeutic implications.
    Uddin MS; Lim LW
    Ageing Res Rev; 2022 Jun; 78():101622. PubMed ID: 35427810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microglia and microglial-based receptors in the pathogenesis and treatment of Alzheimer's disease.
    Wang Z; Weaver DF
    Int Immunopharmacol; 2022 Sep; 110():109070. PubMed ID: 35978514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Environmental Enrichment Potently Prevents Microglia-Mediated Neuroinflammation by Human Amyloid β-Protein Oligomers.
    Xu H; Gelyana E; Rajsombath M; Yang T; Li S; Selkoe D
    J Neurosci; 2016 Aug; 36(35):9041-56. PubMed ID: 27581448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between the morphological subtypes of microglia and Alzheimer's disease neuropathology.
    Paasila PJ; Davies DS; Kril JJ; Goldsbury C; Sutherland GT
    Brain Pathol; 2019 Nov; 29(6):726-740. PubMed ID: 30803086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microglia in Alzheimer's disease.
    Hansen DV; Hanson JE; Sheng M
    J Cell Biol; 2018 Feb; 217(2):459-472. PubMed ID: 29196460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyroptosis in Alzheimer's disease: cell type-specific activation in microglia, astrocytes and neurons.
    Moonen S; Koper MJ; Van Schoor E; Schaeverbeke JM; Vandenberghe R; von Arnim CAF; Tousseyn T; De Strooper B; Thal DR
    Acta Neuropathol; 2023 Feb; 145(2):175-195. PubMed ID: 36481964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptotic neurons and amyloid-beta clearance by phagocytosis in Alzheimer's disease: Pathological mechanisms and therapeutic outlooks.
    Tajbakhsh A; Read M; Barreto GE; Ávila-Rodriguez M; Gheibi-Hayat SM; Sahebkar A
    Eur J Pharmacol; 2021 Mar; 895():173873. PubMed ID: 33460611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypothesis: Modulation of microglial phenotype in Alzheimer's disease drives neurodegeneration.
    Murchison AG
    Alzheimers Dement; 2022 Aug; 18(8):1537-1544. PubMed ID: 34786841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.